
UB679
TargetsMSLN/CD3
IndicationsTumor
ClinicalCN - Preclinical
TherapeuticsOncology
ModalitiesAntibody
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →